Skip to main content
Rizwan Haq, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

RizwanHaqMDPhD

Oncology Boston, MA

Hematologic Oncology, Melanoma

Dana-Farber Cancer Institute, Harvard Medical School

Dr. Haq is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Haq's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2003 - 2006
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2003
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid Tumors  
    Jeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature

Press Mentions

  • Melanoma Research Alliance Announces $8.1 Million in Research Awards
    Melanoma Research Alliance Announces $8.1 Million in Research AwardsApril 27th, 2021

Professional Memberships

Hospital Affiliations